@UofUHematology
Account based inUnited States!
About this account
- Account based in
- United States
- Connected via
- United States Android App
X says this location may be affected by a proxy or VPN.
Account-level information from X, not a live location or the device used for a specific post.
Division of Hematology & Hematologic Malignancies @HuntsmanCancer @UofUInternalMed @UofUHealth
Salt Lake City, UT
Joined January 2023
- Tweets89
- Following42
- Followers176
- Likes44
Welcome Adam DuVall, MD, MPH, to the Division of Hematology and Hematologic Malignancies @huntsmancancer! As Associate Professor of Medicine and Co-Director of our Adolescent & Young Adult (AYA) Program, he brings rare dual expertise in adult and pediatric oncology. @UofUHealth
As the Great Salt Lake recedes, understanding its impact on human health has never been more important. Huntsman Cancer Institute researchers are studying how toxic dust exposure may affect cancer risk and blood health to help protect Utahns. deseret.com/opinion/2026/07/…
Please join us in welcoming Sankalp Arora, MD, to the Division of Hematology & Hematologic Malignancies at @HuntsmanCancer and @UofUMedicine! Dr. Arora joins the Acute Leukemia/MDS team, where he will advance clinical trials in AML. We're excited to welcome him to our faculty! 👏
We're excited to welcome Veronica Guerra, MD, to the Division of Hematology & Hematologic Malignancies at @HuntsmanCancer and @UofUMedicine! Dr. Guerra joins the Acute Leukemia/MDS and BMT/Cellular Therapy team, bringing expertise in leukemia care, research, and transplantation.
UofUHeme retweeted
Excited to share the 1st preprint from my lab! Proud of my amazing team. And thx @TheElfLab the greatest mentor in the 🌎 #CMML
Dysregulated neutrophil extracellular trap formation is a novel driver of clonogenicity and therapeutic vulnerability in CMML biorxiv.org/content/10.64898…
Huntsman Cancer Institute and University of Utah Health are recruiting an MD or MD/PhD to serve as Medical Director of Cellular Therapy. Lead the expansion of a comprehensive cellular therapy network.
Apply today utah.peopleadmin.com/posting…
#CellTherapy #Hematology #PhysicianJobs
The Utah Population Database was awarded $18.6M to launch the Utah Health AI Vault, an initiative to modernize infrastructure, accelerate AI research, and expand access to one of the nation's most powerful population resources! Congratulations to director Dr. Nicola Camp & team!
Congratulations to Dr. Ming Lim, who has received the Advancing Innovation in Bleeding Disorders Award from the Boston Bleeding Disorders Center!
Proud to share that Dr. Tsewang Tashi represented our Mastocytosis Center of Excellence at the American Initiative on Mast Cell Diseases (AIM) Annual Meeting on May 16–17 in Ann Arbor, MI, where he also chaired the session “Novel Therapeutics in Non-Advanced and Advanced SM.”
The University of Utah is pleased to share that Dr. Tsewang Tashi and Dr. Josef Prchal were invited speakers at MPN Asia 2026 on May 9 in Seoul, Korea, where they shared their expertise and engaged with colleagues advancing MPN research and patient care worldwide.
UofUHeme retweeted
Fantastic talk by Dr.Anna Beaudin starting off the ‘Fetal Hematopoiesis and Pediatric AML’ session 🙌🏻 @UofUHematology @UUtah #UofUHeme
to Dr. Gli Fortuna for being accepted into the prestigious ASH CRTI! @ash_hematology @UofUInternalMed @UofUHealth
UofUHeme retweeted
Learned so much at #DAVAHeme, Such a wonderful conference and fun to have great @huntsmancancer representation!! 🩸
The 2026 Whistler DAVA Summit on Hematological Malignancies has come to a close. We extend our gratitude to all participants for their valuable insights, expertise, and engaging questions and answers. #DAVAWhistler
to Drs. Tsewang Tashi and Ahmad Halwani, who received a grant from Servier Pharma to study real-world outcomes of IDH1-mutant AML in the US veteran population!
UofUHeme retweeted
Starting Now: Update on BTK Monotherapy and Combinations in CLL
Moderated by: Dr. Harsh Shah @huntsmancancer
#DAVAWhistler
UofUHeme retweeted
PTRT in R/R cHL around ASCT: Dr. Kelsey Baron of @huntsmancancer presents multi-center data showing improved PFS and OS with PTRT in univariable analysis, but only PFS remained significant after multivariable adjustment. #DAVAWhistler
UofUHeme retweeted
Updated Nivo-AVD data: Dr. Harsh Shah of @huntsmancancer reviews 3-year S1826 follow-up in advanced cHL, with PFS of 91% for N-AVD vs 82% for BV-AVD, and shares real-world Nivo-AVD data showing 1-year PFS of 94.5% and more infections despite G-CSF use. #DAVAWhistler
Welcome Ulrich G. Steidl, MD, PhD to @UofUHealth as Adjunct Professor of Medicine via SAFEP! An internationally recognized leader in myeloid malignancies, stem cell biology & translational science bringing mentorship, & collaboration to the Division of Hematology
🤖 Made with AI
